As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive analyst call entitled Payer Perspectives of Biosimilars: Priorities, Barriers to Entry and Opportunities. This analyst call is open ONLY to subscribers of Decision Resources’ Biosimilars Advisory Service.

Recorded live on Tuesday, July 27, 2010

This 15-minute analyst call answers the following questions:

• Which classes are top priorities for payers to reduce spend on biologics and how have these priorities evolved over time?
• How many biosimilars of each brand will payers reimburse and how will payers decide on which biosimilar(s) to reimburse?
• According to payers, how similar are biosimilars?

Contact us to learn how you can purchase this service and access a recorded playback of this event.

Click here to view the invite.